Results 191 to 200 of about 41,926 (277)

Complications Following Bilateral Salpingectomy by Indication: Population‐Based Cohort Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 5, Page 1056-1064, April 2026.
ABSTRACT Objective Assess the short‐term surgical outcomes of bilateral salpingectomy performed as a standalone procedure, focusing on complication rates by surgical indication and age group. Design Retrospective population‐based cohort. Setting British Columbia, Canada, from January 1st, 2008, to December 31st, 2022.
Alexandra Lukey   +10 more
wiley   +1 more source

Pelvic Exenteration: Oncological and Surgical Outcomes From a Single Tertiary Statewide Service

open access: yesANZ Journal of Surgery, Volume 96, Issue 4, Page 964-971, April 2026.
ABSTRACT Background Advancements in the multidisciplinary management of locally advanced and recurrent rectal cancer, as well as advanced pelvic malignancies, have significantly improved oncological outcomes. Pelvic exenteration is a complex procedure involving en bloc resection of the involved organs with the aim of achieving a microscopic negative ...
Elena T. Blyth   +4 more
wiley   +1 more source

The “White line sign”: A novel sonographic soft marker of pelvic endometriosis

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 4, Page 647-654, April 2026.
The “White line sign” represents thickening of the subperitoneal tissue overlying the anterior pouch of Douglas on transvaginal ultrasound. It demonstrated high specificity for detecting superficial endometriosis and high specificity, sensitivity, and accuracy for deep endometriosis. It was also reproducible and could be a useful soft ultrasound marker
Prubpreet Chaggar   +4 more
wiley   +1 more source

Proportional vascularization along the fallopian tubes and ovarian fimbria: assessment by confocal microtomography. [PDF]

open access: yesRadiol Bras, 2020
Castro PT   +7 more
europepmc   +1 more source

Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real‐World Analysis in Japanese Patients

open access: yesCancer Science, Volume 117, Issue 4, Page 1158-1166, April 2026.
In this study, we investigated the predictive value of tumor mutational burden (TMB) for assessing the efficacy of pembrolizumab in a Japanese cohort. We analyzed real‐world data from 63,952 patients registered in the C‐CAT database who underwent comprehensive genomic profiling, and evaluated the therapeutic efficacy of pembrolizumab in 1899 of these ...
Tomoyo Yasuda   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy